Schedule 13G ownership disclosure

Mirna Therapeutics, Inc.

Security class unavailable · CUSIP: 60470J103

Event date: 2017-06-19

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.1500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-17-007337
Form type
SC 13G
Filer
SYNLOGIC, INC.
CIK
CIK 1527599
Filed
Jun 29, 2017
Reporting period
Jun 19, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub